← All organizations
Highest phase reached
Phase 3
First clinical trial
Apr 1, 2003Last known activity
Oct 30, 2024
Timeline
No events for the selected filters.
Drugs by trial phase (5 distinct, 4 trials)
Phase 3 (2 own, 0 via acquisition)
Phase 2 (3 own, 0 via acquisition)
Indications
Recent trials (4)
- NCT06682572CollaboratorPhase 2Oct 30, 2024
- NCT04063527Lead sponsorPhase 3Jul 20, 2012
- NCT01506856CollaboratorPhase 2/Phase 3May 1, 2010
- NCT00226915Lead sponsorPhase 3Apr 1, 2003
Details
- Last known activity
- Oct 30, 2024